NCT00386750View on ClinicalTrials.gov

Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function

PHASE4TerminatedINTERVENTIONAL
Enrollment

265

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
MalariaFalciparum
Interventions
DRUG

Artemether-lumefantrine

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY